[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350838-105":59,"doc-detail-350838-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","epigenetic-priming-and-locus-specific-demethylation-enhance-cell-death-susceptibility-in-liver-cancer","Epigenetic priming and locus-specific demethylation enhance cell-death susceptibility in liver cancer","","Liver cancer treatment with epigenetic drugs remains difficult because demethylating agents such as 5-azacytidine can trigger genome-wide toxicity and may activate oncogenes. The study tests whether a low, nontoxic dose of 5-AZA primes cancer cells by partially relaxing chromatin at selected loci to restore silenced cell-death regulators. ATAC-seq and RNA-seq in HepG2 cells prioritize BFL-1 and SQOR, and locus-specific CRISPR–dCas9–TET1 demethylation sensitizes cells to TNF-α/CHX while avoiding baseline toxicity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/epigenetic-priming-and-locus-specific-demethylation-enhance-cell-death-susceptibility-in-liver-cancer/350838/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/epigenetic-priming-and-locus-specific-demethylation-enhance-cell-death-susceptibility-in-liver-cancer/350838.png","ImageObject",300,407,{"name":92,"@type":93},"MrHarris58","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is epigenetic drug treatment challenging in liver cancer?","Question",{"text":112,"@type":113},"Demethylating agents like 5-azacytidine can cause genome-wide toxicity and may activate oncogenes, making overall treatment riskier in solid tumors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which genes were prioritized as candidates for restoring cell-death regulation?",{"text":117,"@type":113},"Among ten promoter-opening candidates after 5-AZA treatment, BFL-1 and SQOR were prioritized for their roles in cell death and redox control.",{"name":119,"@type":110,"acceptedAnswer":120},"How does locus-specific demethylation differ from conventional gene overexpression?",{"text":121,"@type":113},"CRISPR–dCas9–TET1 demethylates CpG-rich promoter regions at specific loci, sensitizing cells to TNF-α/CHX more rapidly and reproducing the heightened death response without baseline toxicity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350838,1791451060,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687212988360,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Molecules and Cells Research Article  \nEpigenetic priming and locus-specific demethylation enhance cell-death susceptibility in liver cancer  \nWonjin Woo1 , Seolhee Jeong1 , Ayoung Hwang2 , Su Min Kim 1 , Minjeong Cho 1 , So Hee Dho 1 , Jungmin Choi2 , and Lark Kyun Kim 1 ,⁎  \n1Department of Biomedical Sciences, Graduate School of Medical Science, Brain Korea 21 Project, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06230, Republic of Korea, 2Department of Biomedical Sciences, Korea University College of Medicine, Seoul 02841, Republic of Korea  \n⁎Corresponding [author. LKKIM@yuhs.ac](author. LKKIM@yuhs.ac)[ ](author. LKKIM@yuhs.ac)[https://doi.org/10.1016/j.mocell.2026.100391](https://doi.org/10.1016/j.mocell.2026.100391)  \nABSTRACT  \nLiver cancer treatment with epigenetic drugs remains challenging because demethylating agents such as 5-azacytidine (5-AZA) induce genome-wide toxicity and may activate oncogenes. We hypothesized that a low, nontoxic dose of 5-AZA could prime liver cancer cells by partially relaxing chromatin at selected loci to restore silenced cell-death regulators. HepG2 cells treated with 2 μM 5-AZA underwent ATAC-seq and RNA-seq to identify genes with promoter opening and increased expression. Among ten candidates, BFL-1 and SQOR were prioritized for roles in cell death and redox control. Forced expression of either gene increased sensitivity to TNF-α/cycloheximide (CHX) and sorafenib, both of which elevated mitochondrial reactive oxygen species. To establish causality in a physiological context, we used CRISPR–dCas9–TET1 to demethylate CpG-rich promoter regions of BFL-1 or SQOR. Locus-specific editing sensitized cells to TNF-α/CHX more rapidly than conventional overexpression and reproduced the heightened death response elicited by low-dose 5-AZA without baseline toxicity. Analysis of the cancer cell line encyclopedia and The Cancer Genome Atlas datasets showed consistent BFL-1 downregulation in liver cancer, variable SQOR expression across cancers, and positive correlations of both genes with tumor-suppression markers and immune-cell infiltration. These results indicate that targeted reactivation of BFL-1 and SQOR increases cell-death susceptibility in liver cancer cells. Integrating low-dose pharmacologic priming with precise epigenetic editing may preserve genome-wide methylation while restoring cell-death competence, providing proof-of-concept for locus-specific epigenetic therapy in liver cancer.  \n© 2026 The Author(s) . Published by Elsevier Inc. on behalf of Korean Society for Molecular and Cellular Biology. This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/l](http://creativecommons.org/l)icenses/by-nc-nd/4 .0/) .  \nKeywords: 5-azacytidine, BCL2A1, BCL2-related protein A1, clustered regularly interspaced short palindromic repeat/dCas9-TET1, Sulfide quinone oxidoreductase  \nINTRODUCTION  \nLiver cancer represents the sixth most common malignancy and the third leading cause of cancer-related mortality worldwide, developing predominantly in patients with viral hepatitis, chronic hepatic inflammation, and cirrhosis (Sung et al. , 2021; Villanueva, 2019) . Despite advances in different management modalities, such as surgical resection, locoregional therapies, targeted kinase inhibitors (eg, sorafenib and lenvatinib), and immune-checkpoint blockade, the overall prognosis remains poor, particularly in patients with advanced disease (Yang et al. , 2019) .  \nAmong tumor-intrinsic mechanisms, epigenetic dysregulation has emerged as a hallmark of liver cancer pathogenesis  \nAbbreviations: 5-AZA, 5-azacytidine; BFL-1, BCL2-related protein A1; CHX, cycloheximide; NAC, N-acetyl-L-cysteine; SOR, sorafenib; SQOR, sulfide quinone oxidoreductase; TNF-α, tumor necrosis factor-alpha  \n(Lin et al. , 2025) . Aberrant DNA methylation patterns play dual roles in cancer progression, simultaneously activating oncogenes and silencing tumor suppressor genes (TSG","cbCaicFaJ1s4gBjO","https://ap.wps.com/l/cbCaicFaJ1s4gBjO","pdf",15260068,18,"English","# Abstract\n# Introduction\n## Epigenetic dysregulation and DNA methylation in liver cancer\n## Limitations of global DNMT inhibitors and potential of locus-specific epigenetic editing\n# Background on CRISPR-based epigenome editing","[{\"question\":\"Why is epigenetic drug treatment challenging in liver cancer?\",\"answer\":\"Demethylating agents like 5-azacytidine can cause genome-wide toxicity and may activate oncogenes, making overall treatment riskier in solid tumors.\"},{\"question\":\"Which genes were prioritized as candidates for restoring cell-death regulation?\",\"answer\":\"Among ten promoter-opening candidates after 5-AZA treatment, BFL-1 and SQOR were prioritized for their roles in cell death and redox control.\"},{\"question\":\"How does locus-specific demethylation differ from conventional gene overexpression?\",\"answer\":\"CRISPR–dCas9–TET1 demethylates CpG-rich promoter regions at specific loci, sensitizing cells to TNF-α/CHX more rapidly and reproducing the heightened death response without baseline toxicity.\"}]","Epigenetic priming and locus-specific demethylation enhance cell-death susceptibility in liver cancer | PDF",1790091384,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e2ba64e0a74ce803c0d2d7e30160e47.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/12b363021269060385ba0958d0c44060.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/44c6ac3f3d00608bb6b05175737e1e83.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20e0face7b6c1fb26393782979585504.webp",980,1306]